Tirzepatide
Subcutaneous injection · weeklyA dual GIP/GLP-1 receptor agonist studied for its role in appetite regulation and glucose response.
- Designed to support appetite regulation and reduced food intake
- Studied for its effect on post-meal blood-sugar response
- Often selected for patients pursuing longer-term metabolic support















